King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Mossaed Alyahya
Dr. Mossaed Alyahya is a Senior Consultant Medical Oncologist practising across a broad range of adult solid tumours. He is recognised as a skilled Medical Oncologist delivering guideline-concordant, biomarker-driven systemic therapy in Riyadh, Saudi Arabia.
- Consultant General Medical Oncologist at a JCI-accredited tertiary cancer centre
- Expertise across lung, gastrointestinal, genitourinary, gynaecological and breast malignancies
- Deep experience with chemotherapy, targeted therapy, immunotherapy and endocrine therapy
- Regular participant in multidisciplinary tumour boards guiding complex treatment decisions
- Recommended for international patients seeking personalised general oncology care in Riyadh, Saudi Arabia
Qualifications & Credentials
Medical Degrees
- MBBS — Medical University
- Residency in Internal Medicine — Saudi Board
Fellowships & Special Training
- Fellowship in Medical Oncology
- Advanced training in biomarker-guided cancer therapy
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) Registration
- Member — American Society of Clinical Oncology (ASCO)
- Member — Saudi Oncology Society
Areas of Expertise
Major Conditions Treated
- Lung Cancer
- Colorectal Cancer
- Gastric and Oesophageal Cancer
- Pancreatic and Hepatobiliary Cancer
- Breast Cancer
- Genitourinary Cancers (Prostate, Bladder, Kidney)
- Gynaecological Cancers
- Cancers of Unknown Primary
Sub-specialties
- Systemic Cancer Therapy: Chemotherapy, targeted therapy and immunotherapy for solid tumours — a trusted Medical Oncologist in Riyadh, Saudi Arabia for international patients.
- Precision Oncology: Biomarker-guided decisions using EGFR, ALK, KRAS, HER2, PD-L1 and microsatellite instability testing.
- Supportive & Palliative Oncology: Symptom control and quality-of-life care alongside active cancer treatment.
Advanced Procedures & Treatments
- Systemic Chemotherapy (IV & Oral)
- Targeted Therapy (EGFR, ALK, BRAF, HER2, VEGF inhibitors)
- Immunotherapy (PD-1 / PD-L1 / CTLA-4 inhibitors)
- Hormone Therapy for Breast and Prostate Cancer
- Bone-Modifying Agents (Bisphosphonates, Denosumab)
- Molecular Profiling & Tumour Marker Monitoring
- Port-a-Cath Chemotherapy Administration
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia — Consultant, General Oncology Section, Medical Oncology Department (Present)
Past Affiliations
- Information not publicly available.
Academic & Research Roles
- Participant — Multidisciplinary Tumour Boards (Lung, GI, GU, Breast, Gynae)
- Teaching faculty — Medical Oncology training activities
Key Achievements
- Broad experience across the full spectrum of adult solid tumours
- Active contributor to institutional cancer treatment protocols
- Experienced in managing international patients with complex, multi-line cancer regimens
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Clinical Oncology (ASCO)
- European Society for Medical Oncology (ESMO)
- Saudi Oncology Society
Research & Publications
Published Papers (Selected)
- Information not publicly available.
Ongoing Research & Clinical Interests
- Immunotherapy in advanced solid tumours
- Targeted therapy in lung and GI cancers
- Supportive care and palliative oncology protocols
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (SAR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | SAR 400 – SAR 1,000 | $110 – $265 |
| Chemotherapy (per cycle, regimen-dependent) | SAR 4,000 – SAR 25,000 | $1,065 – $6,660 |
| Targeted Therapy (per month) | SAR 10,000 – SAR 50,000 | $2,665 – $13,335 |
| Immunotherapy (per cycle) | SAR 15,000 – SAR 40,000 | $4,000 – $10,665 |
| Molecular Profiling / NGS Panel | SAR 5,000 – SAR 25,000 | $1,335 – $6,660 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Mossaed Alyahya use in Medical Oncologist treatment?
Dr. Mossaed Alyahya uses modern systemic therapies including molecular-profiling-guided targeted therapy, immunotherapy (PD-1/PD-L1 inhibitors), precision endocrine therapy and bone-modifying agents. Next-generation sequencing is used to personalise treatment. Remote second opinions for international patients are available via Cancer Rounds.
2. What conditions does Dr. Mossaed Alyahya specialize in treating?
Dr. Mossaed Alyahya is a Medical Oncologist specialist treating lung cancer, colorectal cancer, gastric and oesophageal cancer, pancreatic and hepatobiliary cancer, breast cancer, and genitourinary and gynaecological cancers. International patients seeking the best general oncology care in Riyadh, Saudi Arabia are welcomed.
3. How do I book an appointment with Dr. Mossaed Alyahya?
Appointments with Dr. Mossaed Alyahya can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Mossaed Alyahya?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Mossaed Alyahya, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Mossaed Alyahya offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Medical Oncologist specialist in Riyadh, Saudi Arabia.
